Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on Capital EmployedReturn on Invested CapitalTimes Interest Earned

Lifecore Biomedical, Inc. \De\ (LFCR) Return on Capital Employed (2016 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Return on Capital Employed over the past 15 years, most recently at 8.28% for Q2 2025.

  • For Q2 2025, Return on Capital Employed fell 409.0% year-over-year to 8.28%; the TTM value through May 2025 reached 8.28%, down 409.0%, while the annual FY2025 figure was 7.97%, 385.0% down from the prior year.
  • Return on Capital Employed for Q2 2025 was 8.28% at Lifecore Biomedical, Inc. \De\, up from 9.48% in the prior quarter.
  • Over five years, Return on Capital Employed peaked at 0.14% in Q4 2021 and troughed at 27.5% in Q4 2022.
  • A 5-year average of 7.96% and a median of 8.17% in 2025 define the central range for Return on Capital Employed.
  • Biggest five-year swings in Return on Capital Employed: tumbled -2764bps in 2022 and later surged 1617bps in 2023.
  • Year by year, Return on Capital Employed stood at 0.14% in 2021, then plummeted by -19252bps to 27.5% in 2022, then surged by 59bps to 11.32% in 2023, then skyrocketed by 50bps to 5.69% in 2024, then plummeted by -45bps to 8.28% in 2025.
  • Business Quant data shows Return on Capital Employed for LFCR at 8.28% in Q2 2025, 9.48% in Q1 2025, and 5.69% in Q4 2024.